Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Rep. Hank Johnson continues to fight for Americans living with viral hepatitis.
Hepatitis C activist Wayne Starks remains dedicated to staying healthy.
This finding, which is in keeping with initial studies out of China and Italy, is preliminary as the CDC continues to gather data.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
Houstonian Terri Milton is determined not to let advanced fatty liver disease get the best of her.
Scientists and public health officials worldwide collaborate to understand COVID-19 and slow its spread.
Problematic use of alcohol is likely far more common among HIV-positive people than in the general population.
Researchers have called for revised treatment guidelines to address the higher risk of fracture in the HIV population.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
Personal struggles with liver disease led Donna Cryer to advocacy.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
Kaiser Health News takes an in-depth look.
Health advocate David Whiters has mastered some smooth moves since overcoming addiction and hep C.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.